Comparing Strategies for Translating Self-management Support Into Primary Care

Overview

This project will test different ways of helping primary care practices to do a better job of self-management support (SMS) for their patients with diabetes.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Health Services Research
    • Masking: None (Open Label)
  • Study Primary Completion Date: July 31, 2017

Detailed Description

The specific aims of the proposed study are: – Primary Specific Aims 1. To conduct a cluster randomized trial to examine the reach, effectiveness, adoption, implementation and maintenance (RE-AIM) of Connection to Health (CTH) for patients with type 2 diabetes in primary care practice settings. Primary effectiveness outcomes will include hemoglobin A1c, Body Mass Index (BMI), blood pressure and Low Desity Lipprotein (LDL) cholesterol. 2. To determine the incremental benefit, using the RE-AIM framework, of brief targeted practice coaching on the implementation of CTH in diverse primary care practices. – Secondary Specific Aims 1. To identify key practice characteristics (e.g., practice size, organization, setting, and level of experience with practice redesign efforts) that impact CTH RE-AIM. These results will inform dissemination of the CTH intervention. 2. To determine the relative costs associated with implementing CTH and practice coaching to further inform dissemination efforts.

Interventions

  • Behavioral: Self-management support education
    • Same as Arm Description
  • Behavioral: Connection to Health Interactive Behavior Change Technology
    • Same as Arm Description
  • Behavioral: Connection to Health plus Coaching (CTH+C)
    • Same as Arm Description

Arms, Groups and Cohorts

  • Active Comparator: Self-management support education
    • Project staff will meet onsite with practice clinicians for a two-hour session to discuss what self-management support (SMS) is, why it is important, how primary care plays a role in this process, how others have approached it, and how it can be time and cost efficient for them to engage in SMS as part of standard diabetes care. Practices will have access to a website displaying general and local SMS resources. Discussion of the implementation of these resources into the practice will be facilitated. Two additional academic detailing visits will be made to check on progress on SMS adoption, provide additional information as needed, and answer questions. No input will be provided regarding how unique practice characteristics might be utilized for more effective implementation of SMS, and CTH will not be introduced.
  • Active Comparator: Connection to Health Interactive Behavior Change Technology
    • Connection to Health (CTH) Arm: The number and length of staff visits to these practices will be the same as for the SMS Education Arm, but the content of the visits will center on the implementation and use of the CTH program as a way to implement SMS. Clinicians and selected staff members will be given hands-on experience using the system and will be provided with scenarios that will highlight the effective use of CTH as a tool for diabetes SMS. The practices will then implement CTH, using protocols selected from several suggested by the research team. Additional technical assistance with implementing CTH will also be provided as needed.
  • Experimental: Connection to Health plus Coaching
    • Connection to Health plus Coaching (CTH+C) Arm: This arm adds practice coaching as described above to CTH. The active coaching phase focuses on meetings of the practice improvement team, scheduled every other week for approximately 40 minutes each. The improvement team will consist of 6 – 10 diverse representatives of the practice (e.g., front office, medical assistants, physicians). The coach will assist the team in developing a CTH adoption plan and then help them break it down into small bites for rapid cycle change using the Plan-Do-Study-Act quality improvement (QI) model. Active coaching will last for 3 months, followed by monthly calls by the coach to review data regarding the practice’s use of CTH and brief “booster” coaching to deal with problems.

Clinical Trial Outcome Measures

Primary Measures

  • Change in HbA1c from baseline to 18 months
    • Time Frame: 18 months from baseline
    • Glycosylated hemoglobin (HbA1c) will be measured at baseline and 18 months from baseline.
  • Change in LDL from baseline to 18 months
    • Time Frame: 18 months from baseline
    • Low-density lipoprotein (LDL) cholesterol will be measured at baseline and 18 months from baseline (in mg/dL; e.g., 160 mg/dL).
  • Change in systolic and diastolic blood pressure from baseline to 18 months
    • Time Frame: 18 months from baseline
    • Systolic and diastolic blood pressure will be measured at baseline and 18 months from baseline (in mmHg; e.g., 140/90 mmHg)
  • Change in body mass index (BMI) from baseline to 18 months
    • Time Frame: 18 months from baseline
    • Body mass index (BMI) will be measured at baseline and 18 months from baseline (weight (kg) / [height (m)]2; e.g., 24.96)

Secondary Measures

  • Evidence of documented self-management support for patients through medical record review
    • Time Frame: 18 months from baseline
    • The following elements will be assessed in medical record review: presence of a personal care plan with regular updating, evidence of collaborative goal setting, evidence of action planning around prioritized patient goals, evidence of collaborative problem-solving regarding the action planning process, use of community resources to assist in goal attainment, and evidence of ongoing monitoring of progress on identified goals. A total score will be the sum of positive elements.

Participating in This Clinical Trial

Inclusion Criteria

  • Age 21 years old or over – Type 2 Diabetes Mellitus diagnosed for a minimum of 12 months – Able to read in English or Spanish – Plan to remain in the practice during the study period Exclusion Criteria:

  • Developmentally disabled – Decisionally challenged – Pregnant women

Gender Eligibility: All

Minimum Age: 21 Years

Maximum Age: 89 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Colorado, Denver
  • Collaborator
    • University of California, San Francisco
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • W. Perry Dickinson, MD, Principal Investigator, University of Colorado, Denver

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.